Autoimmune thyroiditis Part 3 - Kent Holtorf, MD (2021 Conference) (LDN, low dose naltrexone)

This is Part 3 of Dr. Holtorf’s 3-part series on autoimmune thyroiditis as a core cause of hypothalamic pituitary dysfunction, mitochondrial dysfunction, obesity and systemic illness. This last segment will bring it all together and give practical ways to use this information. 

Autoimmune thyroiditis Part 2 - Kent Holtorf, MD (2021 Conference) (LDN, low dose naltrexone)

This is Part 2 of Dr. Holtorf’s 3-part series on autoimmune thyroiditis as a core cause of hypothalamic pituitary dysfunction, mitochondrial dysfunction, obesity and systemic illness

Autoimmune thyroiditis Part 1 - Kent Holtorf, MD (2021 Conference) (LDN, low dose naltrexone)

Ulcerative Colitis - Pamela Smith, MD, MS (2021 Conference) (LDN, low dose naltrexone)

Treating Children’s Health in a Special Needs Pediatric Practice - Brian Udell, MD (2021 Conference) (LDN, low dose naltrexone)

Rheumatology - Update 2021 - Edyta Biernat-Kaluza, MD, PhD (2021 Conference) (LDN, low dose naltrexone)

Reclaim the Lives of Lupus Patients, A Unique Treatment Approach - Deanna Windham, DO (2021 Conference) (LDN, low dose naltrexone)

PTSD and other mental health treatment with opioid antagonist... - Galyn Forster, MS, LPC (2021 Conference) (LDN, low dose naltrexone)

New approaches to managing fibromyalgia pain - Ginevra Liptan, MD (2021 Conference) (LDN, low dose naltrexone)

Multiple Sclerosis - The role of combination therapy of LDN and Testosterone ... - Harpal Bains, MD (2021 Conference) (LDN, low dose naltrexone)